ofev soft capsules 150 mg
boehringer ingelheim (malaysia) sdn. bhd. - nintedanib esilate -
actilyse 50 mg powder and solvent for solution for injection and infusion (50mg vial)
boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - alteplase - powder and solvent for solution for infusion or injection - alteplase 50 mg - antithrombotic agents
actilyse 20mg powder and solvent for solution for injection and infusion (20mg vial)
boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - alteplase - powder and solvent for solution for infusion or injection - alteplase 20 mg - antithrombotic agents
actilyse 10 mg powder and solvent for solution for injection and infusion
boehringer ingelheim international gmbh - alteplase - powder and solvent for solution for injection/infusion - 10 milligram(s) - enzymes; alteplase
actilyse 20 mg powder and solvent for solution for injection and infusion
boehringer ingelheim international gmbh - alteplase - powder and solvent for solution for injection/infusion - 20 milligram(s) - enzymes; alteplase
actilyse 50 mg powder and solvent for solution for injection and infusion
boehringer ingelheim international gmbh - alteplase - powder and solvent for solution for injection/infusion - 50 milligram(s) - enzymes; alteplase
mobic 7.5mg tablets
boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - meloxicam - tablet - meloxicam 7.5 mg - antiinflammatory and antirheumatic products
mobic
boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - meloxicam - tablet - meloxicam 15 mg - antiinflammatory and antirheumatic products
immukin international unit solution for injection
boehringer ingelheim limited - interferon gamma - solution for injection - international unit - interferons
jardiance 10 mg
boehringer ingelheim israel ltd. - empagliflozin - film coated tablets - empagliflozin 10 mg - linagliptin and empagliflozin - jardiance 10mg is indicated: •to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.•as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus •to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease